Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik
J
J
Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.
Nagler
A
A
Or
R
R
Naparstek
E
E
Cividalli
G
G
Aker
M
M
Mehta
J
J
Mumcuoglu
M
M
Slavin
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D037102:Lectins; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009447:Neuroblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D037121:Plant Lectins; D011879:Radiotherapy Dosage; D030262:Soybean Proteins; D013025:Glycine max; D014182:Transplantation, Autologous / Q000379:methods; D014750:Vincristine / Q000008:administration & dosage; D010835:Phytohemagglutinins
D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D037102:Lectins; D008558:Melphalan; D037121:Plant Lectins; D030262:Soybean Proteins; D014750:Vincristine; C028824:soybean lectin; D010835:Phytohemagglutinins